Business
CBD Unlimited Updates Stakeholders in Interview Via Remote Location at Nasdaq MarketSite
CBD Unlimited Updates Stakeholders in Interview Via Remote Location at Nasdaq MarketSite.
About this update from Endexx Corp.
[{"type":"text","content":"\n Company’s CEO, Todd Davis, discusses second quarter activity CAVE CREEK, AZ, March 31, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CBD Unlimited, Inc. (EDXC), formerly known as Endexx Corporation, a provider of innovative phytonutrient-based food and nutritional products, announced today that the Company was interviewed by reporter Jane King to discuss key activities and updates for its fiscal second quarter.   The update interview will be available on April 6, 2020.   CBD Unlimited’s CEO and Chairman, Todd Davis, had an interview on Friday, March 20, as Nasdaq and Wall Street were going into Coronavirus 19 lockdown mode. Mr. Davis commented that “updating shareholders is critical in these times of uncertainty. CBD Unlimited has set new records in the quarter ending March 31, in spite of a challenging environment, and has accelerated its growth initiatives going forward for the second half of the fiscal year and into 2021.” About CBD Unlimited, Inc. CBD Unlimited, Inc. develops and distributes all-natural CBD products derived from cannabis sativa plant (Hemp), containing less than 0.3% THC. Its products range from oils, capsules, topicals, and pet products, all with the shared purpose of therapeutic and pain relief for humans and pets. Phyto-Bites are CBD soft chews for animal use that are formulated to promote health and support the reduction of separation anxiety, pain, and inflammation. The science behind these products involves over half a decade of research and experiments in order to protect the accuracy in dosage and delivery of absorption per each serving. In the interest of providing conformity with federal and state mandates, the company has incorporated the “Gorilla-Tek” platform into its business practices. The Gorilla-Tek platform is the first standardized hardware agnostic and software solution that tracks high-risk, high-shrink regulated, and restricted products maintained under federal/state/local compliance. The platform provides asset protection, inventory management, compliance and an “end of sale” technology integration. Based on principles developed by the pharmacological industry, the integrated “Gorilla-Tek” platform is tremendously efficient as it provides up-to-the-minute accounting and product details. Gorilla-Tek increases produc...